0.533
Curis Inc Aktie (CRIS) Neueste Nachrichten
CRIS Should I Buy - Intellectia AI
Curis Inc. (CUS0.SG) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Curis, Inc. (CRIS) stock price, news, quote and history - Yahoo Finance Singapore
CRIS Stock Price, Quote & Chart | CURIS INC (NASDAQ:CRIS) - ChartMill
Curis director Kaitin buys $5487 in shares By Investing.com - Investing.com South Africa
Curis director Kaitin buys $5487 in shares - Investing.com UK
Director at Curis (NASDAQ: CRIS) makes open-market share buy - Stock Titan
Curis targets full enrollment in PCNSL registrational study within 12–18 months while advancing CLL proof-of-concept - MSN
Market Review: What are analysts price targets for Curis IncQuarterly Risk Review & Fast Exit and Entry Trade Guides - baoquankhu1.vn
Curis prices private placement of $80.8M - MSN
Aug Big Picture: Is Curis Inc exposed to political riskMarket Sentiment Summary & Weekly Top Gainers Alerts - baoquankhu1.vn
Stonepine Group (NASDAQ: CRIS) reports 4.03M shares, 9.9% stake - Stock Titan
Curis, Inc. 2025 Annual Report: Emavusertib Development, Regulatory Pathways, and Key Business Risks - Minichart
Curis (NASDAQ: CRIS) warns on going concern amid emavusertib push - Stock Titan
CURIS (CRIS) CDO Jonathan Zung converts Series B preferred into 66,667 common shares - Stock Titan
Curis (CRIS) CMO converts Series B preferred stock to common shares - Stock Titan
CURIS INC (CRIS) CFO converts Series B preferred into 66,666 common shares - Stock Titan
Curis (CRIS) CEO converts Series B preferred stock into common shares - Stock Titan
Curis Inc (CRIS) director converts Series B preferred into 26,667 common shares - Stock Titan
Curis, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
[EFFECT] CURIS INC SEC Filing - Stock Titan
Curis Earnings Call: Clinical Momentum Amid Revenue Void - TipRanks
Curis (CRIS) EPS Soars 210.8% to $1.23, But Revenue Plunges 67.1% to $1.1M - AlphaStreet
Curis (CRIS) Q4 2025 Earnings Call Transcript - AOL.com
Curis Inc stock faces renewed scrutiny amid pipeline delays and cash burn concerns - AD HOC NEWS
Curis, Inc. (NASDAQ:CRIS) Q4 2025 Earnings Call Transcript - Insider Monkey
CRIS: HC Wainwright & Co. Reiterates Buy Rating with $17.00 Pric - GuruFocus
Curis reports Q4 results, secures up to $80.8M financing By Investing.com - Investing.com India
Curis Inc (CRIS) Q4 2025 Earnings Call Highlights: A Turnaround with Strong Quarterly Profit ... By GuruFocus - Investing.com Canada
Curis Inc (CRIS) Q4 2025 Earnings Call Highlights: A Turnaround with Strong Quarterly Profit and Strategic Focus - gurufocus.com
Curis Q4 2025 Earnings Call Transcript - MarketBeat
Curis, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Earnings call transcript: Curis Inc. Q4 2025 sees turnaround with net income - Investing.com India
Curis Inc’s NHL Prioritization, PCNSL Timeline Shifts, and CLL Data Delays Clash in 2025 Q4 Earnings Call - Bitget
Curis Reports Progress on Lymphoma Study & Expands CLL Research with EmavusertibNews and Statistics - IndexBox
Curis (CRIS) Q4 2025 Financial Results Conference Call Transcript - Bitget
Earnings call transcript: Curis Inc. Q4 2025 sees turnaround with net income By Investing.com - Investing.com South Africa
Curis Provides Fourth Quarter 2025 Business Update - GuruFocus
Curis: Fourth Quarter Earnings Overview - Bitget
Curis Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Curis (CRIS) Q4 2025 Earnings Call Transcript - The Motley Fool
Curis (CRIS) Reports Lower Than Expected Q4 Revenue - gurufocus.com
Curis Q4 & Full-Year 2025 Financial Results: $19.4M Net Income, $1.1M RevenueNews and Statistics - IndexBox
Curis: Overview of Fourth Quarter Financial Results - Bitget
Curis reports Q4 results, secures up to $80.8M financing - Investing.com
Curis Inc Q4 revenue misses estimates - TradingView
Curis: Q4 Earnings Snapshot - marketscreener.com
Curis (CRIS) swings to Q4 profit but warns of funding shortfall - Stock Titan
Curis’s Emavusertib Trial Pause: What AML and MDS Investors Need to Know - TipRanks
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):